Page 16 - Read Online
P. 16

Page 54                                                         Franz et al. J Transl Genet Genom 2020;4:50-70  I  https://doi.org/10.20517/jtgg.2020.13




                     Ref.
                          [37-54]  [46-55]  [56-63]  [64-70]  [71-77]  [78-81]  [82-85]  [86-92]  [67,93-98]  [97-101]  [102-107]  [56,108-111]  [112-117]

                     Others        x                x        x          x   x   x          x   x  x    x

                     Neuropathy                                                                    
                 Table 1. List of currently known tRNA modifiers (Part A: modification) and aminoacyl-tRNA synthetases (Part B: aminoacylation) that have been associated with ID


                     Hypomyelination                                                               






                     Myopathy                                                                      



                     Seizures                                                                      


                     Ataxia                                                                        

                     Hypotonia                                                                     



                     Microcephaly     x  x          x        x          x   x                  x  x





                     ID  dominant  x  Recessive  x  Recessive  x  Recessive  x  Recessive  x  Recessive  x  Recessive  x  Recessive  x  Recessive  x  Recessive  x  Dominant  x  Recessive  x  Recessive  x  Recessive
                    Chromosome  Localization Recessive/  location  Cytopl  Nucleus  Cytopl/  nucleus  Mito/nucleus  19p13.13  Cytopl  Cytopl/  nucleus  Cytopl/  nucleus  Nucleus  Cytopl/  nucleus  Cytopl/  nucleus  Cytopl  16q24.3  Cytopl/  nucleus  Cytopl  12q24.33















                     Modification  Xp11.23  Cm, Gm,   ncm 5 Um  5p15.31  m 5 C  21q22.3  m 7 G  m 2  2 G  19p13.3  I  11q22.3  mcm 5 U,   mcm 5 s 2 U  2p13.1  t 6 A  4q23  m 1 G  18q12.2  mcm 5 U,   mcm 5 s 2 U  11p13  mcm 5 s 2 U  mcm 5 s 2 U  11q24.2  Ψ  Ψ






                     Mutation  c.[192-2A>G] (G65Cfs*18);   c.[G121+1delG]  (G41fs*V*19); c.[196C>T]   (Q66*); c.[655G>A]   c.[679C-T] (Q227X);   c.[1114C-T] (Q372X);   c.[2035G-A] (G679R)  c.[509G-T] (R170L);   c.[509G-A] (R170Q);   c.[491A-C] (D164A);  c.[940dupC] (L314Pfs*16);   c.[911_927dup]   (Q310Gfs*30)  c.[1506+1G-T];   c.[1332_1333delGT]   (Y445Lfs*28);   c.[657_688del32]   (Q219Hfs*22)   c.[382G-A] (V128M);  c.[99_106dupGAGCCCGG]   c.[1660C-T] (R554X);   (W599Gf


                        Part A: modification  (D219N)            (E36Gfs*44)  c.[1794delC]   (T555P);   (H271R)  (S394Cfs*18)




                     Gene  FTSJ1   NSUN2  WDR4      TRMT1    ADAT3  ALKBH8  KEOPS  TRMT10A  ELP2  ELP4  CTU2  PUS3  PUS1
   11   12   13   14   15   16   17   18   19   20   21